Literature DB >> 25953828

ACTH after 15 min distinguishes between Cushing's disease and ectopic Cushing's syndrome: a proposal for a short and simple CRH test.

Katrin Ritzel1, Felix Beuschlein1, Christina Berr1, Andrea Osswald1, Nicole Reisch1, Martin Bidlingmaier1, Harald Schneider1, Jürgen Honegger1, Lucas L Geyer1, Jochen Schopohl1, Martin Reincke2.   

Abstract

OBJECTIVE: The aim of the present study was to validate criteria of corticotropin-releasing hormone (CRH) stimulation and 8 mg dexamethasone suppression (high-dose dexamethasone suppression, HDDS) to distinguish the etiology of ACTH-dependent Cushing's syndrome. SUBJECTS AND METHODS: We retrospectively analyzed cortisol and ACTH after the injection of 100 μg human CRH in confirmed Cushing's disease (CD, n=78) and confirmed ectopic Cushing's syndrome (ECS, n=18). Cortisol and ACTH increase (in percentage above basal (%B)) at each time point, maximal increase (Δmax %B), and area under the curve (AUC %B) were analyzed using receiver operator characteristics (ROC) curve analyses. Cortisol suppression (%B) after 8 mg of dexamethasone was evaluated as a supplementary criterion.
RESULTS: An increase in ACTH of ≥ 43%B at 15 min after CRH was the strongest predictor of CD, with a positive likelihood ratio of 14.0, a sensitivity of 83%, a specificity of 94%, a positive predictive value of 98% and a negative predictive value of 58%. All of the other criteria of stimulated ACTH and cortisol levels were not superior in predicting CD in response to CRH injection. The addition of cortisol suppression by dexamethasone did not increase the discriminatory power. However, the combination of a positive ACTH response at 15 min and a positive HDDS test excluded ECS in all cases.
CONCLUSION: The present findings support the use of plasma ACTH levels 15 min after the injection of human CRH as a response criterion for distinguishing between CD and ECS. The addition of the HDDS test is helpful for excluding ECS when both tests are positive.
© 2015 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25953828     DOI: 10.1530/EJE-14-0912

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.

Authors:  Mattia Barbot; Laura Trementino; Marialuisa Zilio; Filippo Ceccato; Nora Albiger; Andrea Daniele; Anna Chiara Frigo; Rodica Mardari; Giuseppe Rolma; Marco Boscaro; Giorgio Arnaldi; Carla Scaroni
Journal:  Pituitary       Date:  2016-10       Impact factor: 4.107

Review 2.  Consensus on diagnosis and management of Cushing's disease: a guideline update.

Authors:  Maria Fleseriu; Richard Auchus; Irina Bancos; Anat Ben-Shlomo; Jerome Bertherat; Nienke R Biermasz; Cesar L Boguszewski; Marcello D Bronstein; Michael Buchfelder; John D Carmichael; Felipe F Casanueva; Frederic Castinetti; Philippe Chanson; James Findling; Mônica Gadelha; Eliza B Geer; Andrea Giustina; Ashley Grossman; Mark Gurnell; Ken Ho; Adriana G Ioachimescu; Ursula B Kaiser; Niki Karavitaki; Laurence Katznelson; Daniel F Kelly; André Lacroix; Ann McCormack; Shlomo Melmed; Mark Molitch; Pietro Mortini; John Newell-Price; Lynnette Nieman; Alberto M Pereira; Stephan Petersenn; Rosario Pivonello; Hershel Raff; Martin Reincke; Roberto Salvatori; Carla Scaroni; Ilan Shimon; Constantine A Stratakis; Brooke Swearingen; Antoine Tabarin; Yutaka Takahashi; Marily Theodoropoulou; Stylianos Tsagarakis; Elena Valassi; Elena V Varlamov; Greisa Vila; John Wass; Susan M Webb; Maria C Zatelli; Beverly M K Biller
Journal:  Lancet Diabetes Endocrinol       Date:  2021-10-20       Impact factor: 32.069

Review 3.  Two types of ectopic Cushing syndrome or a continuum? Review.

Authors:  Marta Araujo Castro; Mónica Marazuela Azpiroz
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

Review 4.  Pitfalls in Performing and Interpreting Inferior Petrosal Sinus Sampling: Personal Experience and Literature Review.

Authors:  Jordan E Perlman; Philip C Johnston; Ferdinand Hui; Guy Mulligan; Robert J Weil; Pablo F Recinos; Divya Yogi-Morren; Roberto Salvatori; Debraj Mukherjee; Gary Gallia; Laurence Kennedy; Amir H Hamrahian
Journal:  J Clin Endocrinol Metab       Date:  2021-04-23       Impact factor: 5.958

5.  Case Report: A Challenging Localization of a Pulmonary Ectopic ACTH-Secreting Tumor in a Patient With Severe Cushing's Syndrome.

Authors:  Andreea Liliana Serban; Lorenzo Rosso; Paolo Mendogni; Arianna Cremaschi; Rita Indirli; Beatrice Mantovani; Mariagrazia Rumi; Massimo Castellani; Arturo Chiti; Giorgio Alberto Croci; Giovanna Mantovani; Mario Nosotti; Emanuele Ferrante; Maura Arosio
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-09       Impact factor: 5.555

6.  RELIABILITY OF THE CORTICOTROPIN RELEASING HORMONE STIMULATION TEST FOR DIFFERENTIATING BETWEEN ACTH DEPENDENT AND INDEPENDENT CUSHING SYNDROME.

Authors:  O Polat Korkmaz; B Karayel; M Korkmaz; O Haliloglu; S Sahin; E Durcan; M M Oren; P Kadioglu
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Apr-Jun       Impact factor: 0.877

7.  Adrenal vein sampling for ACTH-producing pheochromocytomas.

Authors:  Nicholas Leader; Alexander Ushinsky; Christopher D Malone
Journal:  Radiol Case Rep       Date:  2021-07-15

8.  Indication to dynamic and invasive testing in Cushing's disease according to different neuroradiological findings.

Authors:  E Ferrante; M Barbot; A L Serban; F Ceccato; G Carosi; L Lizzul; E Sala; A Daniele; R Indirli; M Cuman; M Locatelli; R Manara; M Arosio; M Boscaro; G Mantovani; C Scaroni
Journal:  J Endocrinol Invest       Date:  2021-10-26       Impact factor: 4.256

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.